Nemaura Medical Inc. (OTC BB:NMRD), (“Nemaura”), a medical device company developing a non-invasive, needle-free, pain-free, daily-disposable, and cost effective wireless CGM (Continuous Glucose Monitoring) patch known as sugarBEAT® today announced that its multicentre open label clinical study has been selected for poster exhibit at the Advanced Technologies and Treatments for Diabetes (ATTD) Conference in Paris from the 15th to 18th February 2017.
Info:
www.businesswire.com/news/home/20170215005502/en/Nemaura-Medical-present-sugarBEAT%C2%AE-Poster-Advanced-Technologies
Info:
www.businesswire.com/news/home/20170215005502/en/Nemaura-Medical-present-sugarBEAT%C2%AE-Poster-Advanced-Technologies
No comments:
Post a Comment